<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">The global community has made extraordinary strides in scaling up treatment for people living with HIV/AIDS over the past two decades. Since 2000, there has been a 30-fold increase in people accessing antiretroviral therapy (ART) globally from 250,000 people to more than 17 million people in 2015 [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR2">2</xref>]. The rate of new infections globally has also come down in the last decade from 3.3 million new infections in 1998 to 2.1 million in 2015 [
 <xref ref-type="bibr" rid="CR2">2</xref>]. This success has been driven, in part, by an unprecedented increase in financial resources, with annual funding levels increasing from US$5 billion in 2003 to US$19.2 billion in 2014 [
 <xref ref-type="bibr" rid="CR3">3</xref>].
</p>
